Dr McGregor on the Updated NCCN Guidelines for Non–Clear Cell RCC

Using Combination Therapy as Treatment of Non-Clear Cell RCCПодробнее

Dr. McGregor on Challenges Facing Frontline Treatments for RCCПодробнее

Updates, Challenges, and Unmet Needs in nccRCC TreatmentПодробнее

Current Perspectives on Non Clear Cell RCCПодробнее

Risk Stratification in Metastatic Renal Cell CarcinomaПодробнее

Dr. McGregor on the Evolving Treatment Landscape of RCCПодробнее

Dr. McGregor on New Combinations With Immunotherapy in RCCПодробнее

Dr. McGregor on Unmet Needs in Non-Clear Cell RCCПодробнее

Ask The Expert About Non-Clear Cell Renal Cell Carcinoma (nccRCC) ManagementПодробнее

Dr. McGregor on Unmet Needs in Advanced RCCПодробнее

Review of the Data of Frontline Treatment for Non-Clear Cell Kidney CancerПодробнее

Treating Non-Clear Cell Renal Cell CarcinomaПодробнее

Focus on Nonclear Cell RCC: Frontline Treatment Options, Research Limitations, and MoreПодробнее

IKCS 2020: Non-Clear Cell RCC SessionПодробнее

KCRS21: Non Clear Cell RCCПодробнее

Dr. McGregor on Whether Patients Need Frontline Combinations in RCCПодробнее

Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationaleПодробнее

Dr. Sznol Discusses Immunotherapy in Non-Clear Cell Renal CancerПодробнее

Dr. Jonasch on Molecular Understanding of Clear Cell RCCПодробнее